These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7297923)

  • 21. Do the CD45RO+CD8+ intestinal intraepithelial T lymphocytes have the characteristics of memory cells?
    Ebert EC
    Cell Immunol; 1993 Apr; 147(2):331-40. PubMed ID: 8453675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U; Rindsfüser M; Grussenmeyer T; Schultze-Seemann W; Wetterauer U
    Br J Cancer; 2000 Sep; 83(5):637-41. PubMed ID: 10944605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma.
    Kim TY; von Eschenbach AC; Filaccio MD; Hayakawa K; Parkinson DR; Balch CM; Itoh K
    Cancer Res; 1990 Sep; 50(17):5263-8. PubMed ID: 2143685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.
    Koch M; Beckhove P; Op den Winkel J; Autenrieth D; Wagner P; Nummer D; Specht S; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Weitz J
    Ann Surg; 2006 Dec; 244(6):986-92; discussion 992-3. PubMed ID: 17122624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells.
    Hutchinson GH; Heinemann D; Symes MO; Williamson RC
    Br J Cancer; 1981 Sep; 44(3):396-402. PubMed ID: 7284236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.
    Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun SD; Holmes EC; Golub SH
    Cancer Res; 1988 Mar; 48(5):1180-3. PubMed ID: 3257716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S; Whiteside TL; Moretta L; von Fliedner V
    J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.
    Bateman WJ; Donnellan I; Fraser IA; Wong LS; Morris AG
    Cancer Immunol Immunother; 1995 Jul; 41(1):61-7. PubMed ID: 7641220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of activated lymphocytes in colon cancer.
    Ebert EC; Brolin RE; Roberts AI
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):72-81. PubMed ID: 2783402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area.
    Ostenstad B; Lea T; Schlichting E; Harboe M
    Gut; 1994 Mar; 35(3):382-7. PubMed ID: 8150352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of protein kinase C activation in human lamina propria T lymphocytes: influence of intestinal mucosa on T cell reactivity.
    Qiao L; Schürmann G; Betzler M; Meuer SC
    Eur J Immunol; 1991 Oct; 21(10):2385-9. PubMed ID: 1680696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients.
    James SP; Fiocchi C; Graeff AS; Strober W
    Gastroenterology; 1986 Dec; 91(6):1483-9. PubMed ID: 2945749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characteristics of lymphocytes isolated from the rat large intestine. Response to T-cell mitogens and natural killer cell activity.
    Nauss KM; Pavlina TM; Kumar V; Newberne PM
    Gastroenterology; 1984 Mar; 86(3):468-75. PubMed ID: 6607187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extravascular natural cytotoxicity in man: Anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes.
    Moore M; Vose BM
    Int J Cancer; 1981 Mar; 27(3):265-72. PubMed ID: 6169658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
    Wang YL; Si LS; Kanbour A; Herberman RB; Whiteside TL
    Cancer Res; 1989 Nov; 49(21):5979-85. PubMed ID: 2507139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node anti-tumour effector cell mechanisms in colorectal carcinoma.
    Werkmeister JA; Pihl E; Flannery GR
    Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):115-24. PubMed ID: 7259635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
    Itoh K; Tilden AB; Balch CM
    Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of antitumor activity and experimental expansion of human lung cancer-infiltrating lymphocytes.
    Xu Z; Shao J; Zhang Y; Li D; Li Y; Ba D
    Chin Med Sci J; 1991 Jun; 6(2):87-91. PubMed ID: 1804382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro.
    Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH
    Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.